BioMark Diagnostics Stock

BioMark Diagnostics P/B

The P/B (Price-to-Book Ratio) of BioMark Diagnostics (BUX.CN) as of Aug 11, 2026 is 32.60. In the previous year, P/B (Price-to-Book Ratio) was -93.09 — a change of -135.01% (higher).

P/B

32.60

YoY

-135.01%

Last updated:

P/B (Price-to-Book Ratio) of BioMark Diagnostics is 2026 32.60 . P/B (Price-to-Book Ratio) of BioMark Diagnostics was 2025 -93.09 . It decreases by -135.01% higher compared to the previous year.
Access this data via the Eulerpool API

BioMark Diagnostics Stock analysis

What does BioMark Diagnostics do? BioMark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioMark Diagnostics stock

P/B (Price-to-Book Ratio) of BioMark Diagnostics is 32.60 in 2026.

P/B (Price-to-Book Ratio) of BioMark Diagnostics changed from -93.09 to 32.60, representing a -135.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) BioMark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s BioMark Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — BioMark Diagnostics

All Key Metrics — BioMark Diagnostics